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ABSTRACT 
 
The rearranged during transfection (RET) gene encodes a single-pass receptor 
whose proper expression and function are essential for the development of enteric 
nervous system (ENS). Mutations in RET regulatory regions are also associated with 
Hirschsprung’s disease (HSCR) (aganglionosis of the colon). We have previously 
showed that two polymorphisms in RET promoter are associated with the increased risk 
of HSCR.  These SNPs overlap with the NK2 homeobox 1 (Nkx2-1) binding motif 
interrupting the physical interaction of NKX2-1 with the RET promoter and result in 
reduced RET transcription. In this study, we further delineated Nkx2-1 mediated RET 
transcription.  First, we demonstrated that PHOX2B, like SOX10 and NKX2-1, is 
expressed in the mature enteric ganglions of human gut.  Second, subsequent dual-
luciferase-reporter studies indicated that Nkx2-1 indeed works co-ordinately with 
Phox2b and Sox10, but not Pax3, to mediate RET transcription. In addition, 
identification of Phox2b responsive region in RET promoter further provides solid 
evidence of the potential functional interaction between Phox2b and RET. In sum, 
Phox2b and Sox10 act together with Nkx2.1 to modify RET signalling and this 
interaction may also contribute to HSCR susceptibility. 
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INTRODUCTION 
 
Neural crest cells are multipotent cells which arise from the dorsal region of the 
fusing neural tube. During embryogenesis, neural crest cells migrate to their target 
regions and differentiate into different structures including enteric nervous system (ENS) 
which controls the blood flow, absorption, secretion and motility of the gut. 
The rearranged during transfection (RET) gene encodes a single-pass 
transmembrane receptor whose expression and proper function are crucial for the 
migration and differentiation of neural crest cell-derived enteric neuron progenitors, 
hence, the development of ENS (Schuchardt et al., 1994). Indeed, RET is the major gene 
implicated in Hirschsprung’s disease (HSCR) which is characterized by the absence of 
enteric ganglia in the gut region. Transcription of RET is a complex process that 
involves the dynamic interaction of transcription factors with the core promoter, other 
regulatory sequences, such as enhancer and repressor sequences. Any alteration in such 
a complicated mechanism may lead to defective RET expression which may be 
associated not only with the HSCR but also with the variability presented by the HSCR 
phenotype.  
NKX2-1, PHOX2B, SOX10 and PAX3 are crucial for the development of neural 
crest cells. Importantly, all these transcription factors are involved in RET transcription. 
There is no Ret expression in the homozygous Phox2b-knockout mice which presents 
with a phenotype reminiscent of HSCR in humans (Pattyn et al., 1999). Genetically, 
Phox2b polymorphisms also interact with RET polymorphisms to increase the risk of 
HSCR (Miao et al., 2007). 
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It has been demonstrated that Pax3 is required for enteric ganglia formation and 
that Pax3 and Sox10 regulate c-ret in a synergistic manner through activation of a 
conserved Sox10/Pax3-responsive enhancer (Lang and Epstein, 2003). In fact, 
mutations in SOX10 are associated with syndromic HSCR cases (Waardenburg 
Syndrome type IV) which are characterized by the auditory-pigmentary defects and 
HSCR phenotype.  
NK2 homeobox 1 (NKX2-1), which was previously known as thyroid 
transcription factor 1 (TTF1), binds to the RET promoter and transactivates RET 
transcription (Garcia-Barcelo et al., 2005). Since all these transcription factors play 
crucial roles in regulating RET transcription in enteric neural crest cells, we set out to 
investigate whether Nkx2-1 co-operated with Phox2b, Sox10 or Pax3 in the regulation 
of RET transcription.  
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MATERIALS AND METHODS 
Cell cultures 
A human (SK-N-SH) and a mouse (Neuro-2A) neuroblastoma cell lines were 
cultured in complete growth medium: Dubelcco’s Modified Eagle Medium (DMEM) 
(Gibco, USA) supplemented with heat inactivated 10% fetal bovine serum, 2mM of L-
glutamine, 100U/ml penicillin and 100μg/ml streptomycin (Penicillin-Streptomycin) 
(Gibco, USA) at 37 oC, 5% CO2. 
 
RNA extraction and reverse transcriptase polymerase chain reaction (RT-PCR) 
RT-PCR was also performed to examine the expression of Ret, Nkx2-1, Phox2b, 
Sox10 and Pax3 in the cell lines used. Total RNA was extracted from cell lines with 
TRIzol® Reagent (Invitrogen, Carlsbad, CA, USA) according to manufacturer’s 
instruction. RT-PCR was performed using 2µg of total RNA with the SuperScriptTM 
One-Step RT-PCR Systems (Invitrogen, Carlsbad, CA, USA). Conditions of the PCR 
are summarized in Table 1. 
 
Gene/Amplicon Primers Tm (°C)
RET Forward: 5’-ACA CCA AGG CCC TGC GGC G-3’ 
Reverse: 5’-GGA AGG TCA TCT CAG CTG AG-3’ 54 
Ret Forward: 5’-GCT GCA TGA GAA TGA CTG GA-3’ Reverse: 5’-GAA GGA GTA GGC CCT GGG TA-3’ 60 
NKX2-1 Forward: 5’-ACG TGA GCA AGA ACA TGG C-3’ Reverse: 5’-GGT GGT TCT GGA ACC AGA TC-3’ 56 
Phox2b Forward: 5’-AGT CCTGTA TGG CTG GGA TG-3’ Reverse: 5’-ACC ACC AGA GCA GTC CGT AC-3’ 54 
Sox10 Forward: 5’- ATG CAG CAC AAG AAA GAC CA-3' Reverse:  5’- ATA GGG TCC TGA GGG CTG AT-3’ 60 
Pax3 Forward: 5’-GGA GGC GGA TCT AGA AAG GAA G-3’ Reverse:  5’-CCC CCG GAA TGA GAT GGT TGA A-3’ 56 
RET-372bp Forward: 5’-CCC GCA CTG AGC TCC TAC-3’ Reverse: 5'-CGC CCG TGC GCG-3' 56 
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RET-200bp Forward: 5’-GCC TAG CTT CAG TCC CGC-3’ Reverse: 5'-CGC CCG TGC GCG-3' 56 
RET-100bp Forward: 5’-GGG CGG GGA TGG GGC GGC-3’ Reverse: 5'-CGC CCG TGC GCG-3' 56 
Table 1. Summary of primers used in this study. 
 
Immunohistochemistry  
Immunohistochemical study was performed on human gut. Samples were fixed and 
embedded in paraffin, subsequently sectioned and mounted on glass slides. Anti-
Phox2b (1:800, a gift from Stanisla Lyonnet, Necker Enfants Malades Hospital, France) 
and anti-Ret (1:100, Neuromics, Edina, MN) antibodies were used for 
immunohistochemistry. For histological analysis, paraffin sections of human gut were 
rehydrated using standard protocols and microwaved for 10 min in 10mM sodium 
citrate pH6.0.  Sections were then incubated with the antibodies followed by incubation 
with secondary antibodies , anti-goat-IgG-Texas Red (1:200, Molecular Probe, Eugene, 
OR) and anti-rabbit-IgG-FITC  (1:200, Calbiochem, San Diego, CA) and mounted with 
aqueous mounting media (Vector, Burlingame, CA).   
 
Construction of vectors 
Luciferase-reporter plasmid 
About 3.7kb of the human RET promoter (from the nucleotide 1545 to 5270 of 
the GenBank accession number AF032124) was cloned upstream of the luciferase 
reporter in the pXP1 vector (GenBank accession no. AF093683) as previously described 
(Garcia-Barcelo et al., 2005). In order to generate the sequential deletion reporter 
constructs, different lengths of the RET promoter (372bp, 200bp and 100bp DNA 
fragments upstream of the RET transcription start site) were amplified by PCR. The 
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PCR products were then subcloned into the pGL3-Basic vector (Promega, USA) 
upstream of the Firefly luciferase gene. Conditions of the PCR are summarized in Table 
1. 
 
Nkx2-1, Phox2b, Sox10 and Pax3 expression vectors 
Nkx2-1-, and Phox2b- expression vectors were the gifts from Dr. Parviz Minoo 
(University of Southern California, Los Angeles, CA, USA) (Hamdan et al., 1998) and 
Dr. Diego Fornasari (University of Milan and CNR-Institute of Neuroscience, Milan, 
Italy), respectively. Sox10 expression construct was purchased from OriGene 
Technologies, Inc. (Rockville, Maryland, USA). The mouse Pax3 cDNA was obtained 
from Prof. Peter Gruss (Max Planck Institute of biophysical chemistry, Department of 
Molecualr Cell Biology, Göttingen, Germany) and then subcloned into pcDNA3.1 at 
HindIII and XhoI sites.  
 
Transient transfection and dual-luciferase assay 
In order to assess the transactivation activity of each transcription factor on the 
RET promoter, SK-N-SH (2x104) or Neuro-2A (3x105) cells were plated on tissue 
culture plates 24 hours prior to transfection. Cells were transiently co-transfected with 
50ng pRL-SV40, 300ng reporter constructs and appropriate amount of Nkx2-1, Phox2b-, 
Sox10- or Pax3- expression vector as indicated using 1.25μl Lipofectamine™2000 
(Invitrogen, USA). 
Cells were then lysed and the luciferase activity was analyzed with the Dual-
Luciferase Reporter Assay System (Promega) on a MicroLumatPlus LB 96V instrument 
(Berthold Technology). The activity of RET promoter was expressed as relative 
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luciferase unit (RLU) after normalized with the internal control (Renilla luciferase). The 
experiments were performed at least three times each in triplicate. The bar chart 
represents the mean value of RLU +/- standard derivation (SD). 
 
Statistical analysis and in silico prediction of Phox2b binding site in the RET 
promoter 
Statistical analysis of the luciferase data was performed with one-way ANOVA. 
The significance level was set at 5%. Tukey’s test was used for post hoc pair-wise 
comparisons. 
The transcription factor binding sites were predicted by the Matinspector 
program (http://www.genomatix.de/) with default parameters. 
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RESULTS 
 
Differential expression of Nkx2-1, Phox2b, Sox10 and Pax3 in two neuroblastoma 
cell lines 
Nkx2-1, Phox2b, Sox10 and Pax3 are four key transcription factors for Ret 
expression.  Thus, we first evaluated their expression in one human (SK-N-SH) and one 
mouse (Neuro-2A) neuroblastoma cell lines by RT-PCR. As shown in Figure 1, Ret, 
Nkx2-1 and Phox2b were expressed in these two neuroblastoma cell lines; while Pax3 
was only expressed in Neuro-2A and neither of these cell lines expresses Sox10. It is 
mention-worthy that PHOX2B, endogenously expressed in SK-N-SH, contains a 20bp 
deletion in the polyalanine tract that introduces a premature termination codon and 
results in a truncated protein (van Limpt et al., 2004). Since Ret is expressed in both 
SK-N-SH and Neuro-2A, these two neuroblastoma cell lines were used to delineate the 
transcriptional regulation of Ret expression in this study. 
 
PHOX2B is expressed in the myenteric plexus of human adult gut 
Previous study from our group have shown that NKX2-1 is expressed in enteric 
ganglions of prenatal and postnatal guts (Garcia-Barcelo et al., 2005), and PHOX2B 
was also detected in the enteric ganglia of the developing ENS (Amiel et al., 2003). 
Given that NKX2-1 and PHOX2B are co-expressed in these two neuroblastoma cell 
lines, we speculated that PHOX2B may be also persistently expressed even in the 
postnatal stage. To address this question, we have performed immunohistochemistrial 
study using sections from human postnatal gut. As shown in Figure 2, the ganglion cells 
in myenteric plexus are expressing RET (red) and also costained with PHOX2B (green), 
 9
indicating that PHOX2B are persistently coexpressed with RET in enteric ganglions in 
both embryonic and postnatal stages.  
 
Activation of RET promoter by Nkx2-1, Sox10 and Pax3 
The differential expression of Nkx2-1, Sox10 and Pax3 in SK-N-SH and Neuro-
2A prompted us to examine their potential transactivation function on RET promoter in 
these cell lines. We used a reporter construct which contains ~3.7kb 5’flanking 
sequence of RET promoter spanning -3527 to +194 relative to the transcription start site. 
Within this region, we found binding motifs for Nkx2-1, Sox10 and Pax3, but not 
Phox2b, as summarized in Figure 3A. As indicated, Nkx2-1 binding motif is adjacent to 
transcription start site at -5. On the other hand, the binding sites for Sox10 and Pax3 are 
located further upstream at -3417 and -3398, respectively. 
To examine the transactivation activity of these transcription factors, luciferase 
reporter assays were performed using this ~3.7kb RET promoter construct and the 
Neuro-2A cells. Overexpression of Nkx2-1 significantly activated the RET promoter by 
6.5 folds when compared with the vector control (Figure 3B). Similarly, Sox10 (Figure 
3C) and Pax3 (Figure 3D) also elevated the promoter activity by 2.7 and 2 folds, 
respectively. It is noteworthy that these transcription factors also upregulated the RET 
promoter with similar extent in SN-K-SH (data not shown). Taken together, all these 
three transcription factors could significantly upregulate the RET promoter activity in 
both neuroblastoma cell lines tested. 
 
-178/-6 of RET promoter is crucial for Phox2B mediated transcription  
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In Figure 4A, we found that Phox2b also increases the promoter activity of RET 
(~1.8 folds, p<0.05) in Neuro-2A, it is consistent with the previous finding (Bachetti et 
al., 2005). Bachetti et al. also showed that the putative binding site(s) for Phox2b may 
reside at the region between -307 and +53 of the RET promoter relative to the 
transcription start site. To further identify the putative Phox2b binding site, three 
additional 5’ deletion reporter constructs were generated which contain the regions 
spanning -178 to +194 (RET-372bp), -6 to +194 (RET-200bp) and  +94 to +194 (RET-
100bp) of the RET promoter relative to the transcription start site. Consistently, Phox2B 
increased the luciferase activity by 1.8 folds with the proximal 372bp of RET promoter 
(RET-372bp) and it was comparable to that of the full length promoter (Figure 3A & B). 
Deletion of the additional 172bp (RET-200bp) from the 5’ end resulted in a ~80% 
reduction in the transcriptional activity, suggesting the presence of a putative Phox2B 
binding site(s) in this 172bp (Figure 4B). 
Subsequent bioinformatic analysis revealed that this 172bp DNA fragment 
contains multiple putative binding motifs for numerous transcription factors including 
GC-Box factor SP1, Kruppel-like factor (KLF) and vertebrate homologues of enhancer 
of split complex (HES1) etc as indicated in Figure 4C. Nevertheless, no putative 
Phox2b binding site (‘ATTA’ or ‘TAAT’) was found in this region (Figure 4C). 
 
Sox10, Phox2b and Nkx2-1 work coordinately to mediate RET transcription 
Given that 1) the above transcription factors are important for the expression of 
RET and they upregulate RET promoter activity; 2) Sox10, Pax3 and Nkx2-1 physically 
bind to the RET promoter (Garcia-Barcelo et al., 2005;Lang and Epstein, 2003); and 3) 
Nkx2-1 only transactivate RET transcription in the presence of Sox10 and Pax3 binding 
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sites (Garcia-Barcelo et al., 2005), we then examined whether Phox2b, Sox10 or Pax3 
work coordinately with Nkx2-1 in stimulating RET transcription. In order to evaluate 
the functional interaction between these transcription factors on RET transcription, 
similar luciferase assays were performed using the Neuro-2A cells in which Nkx2-1 
was co-transfected with Phox2b, Sox10 or Pax3.  
Co-expression of Phox2b with Nkx2-1 showed significantly higher luciferase 
activity (4.2-fold) when compared with either Nkx2-1 (2.9-fold) or Phox2b (1.8-fold) 
alone (Figure 5A), suggesting that Phox2b can enhance Nkx2-1 induced RET promoter 
activity. Similar coordination was also found when Nkx2-1 was co-transfected with 
Sox10 in which 3.9-fold increment in promoter activity was seen, while Nkx2-1 or 
Sox10 alone only elevated luciferase activity by 1.8-fold and 1.9-fold, respectively 
(Figure 5B). Unlike Phox2b or Sox10, over-expression of Pax3 could not further 
enhance Nkx2-1-activated RET transcription. Only 1.8-fold increment of the RET 
promoter activity was detected when Pax3 was coexpressed with Nkx2-1 (Figure 5C). 
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DISCUSSION 
Proper gene expression is tightly regulated by dynamic assembly of transcription 
complex in the regulatory sequence of the gene which involves the binding of 
transcription factors specifically to their consensus DNA sequences, protein-protein 
interaction among enhancers, repressors as well as other cofactors. Aberrant gene 
expression may lead to disease. In this study, we demonstrated that 1) PHOX2B, like 
NKX2-1, is persistently expressed not only in the prenatal, but also in the postnatal 
enteric ganglions; 2) Nkx2-1, Phox2b, Sox10 and Pax3 stimulate RET transcription 
individually in neuroblastoma cells; 3) the -6/-178 region of the RET promoter is 
essential for Phox2b-activated RET transcription; 4) Phox2b or Sox10 interact with 
Nkx2-1 to mediate RET transcription; 5) Nkx2-1 does not co-operate with Pax3 in RET 
transcription.   
NKX2-1, PHOX2B, SOX10 and PAX3 are dispensable for RET expression 
(Garcia-Barcelo et al., 2005;Pattyn et al., 1999;Lang and Epstein, 2003) and have been 
associated with the defective ENS development (HSCR). Here, we found that NKX2-1 
(Garcia-Barcelo et al., 2005), SOX10 (Fu et al., 2003) and PHOX2B are co-expressed 
with RET in enteric ganglions of the postnatal gut. We believed that these factors may 
not only contribute to ENS development, but also the maintenance of RET expression in 
the mature enteric ganglions. 
Like Nkx2-1, Sox10 and Pax3, Phox2b alone was also able to up-regulate RET 
transcription. Nevertheless, there is no known Phox2b binding site identified in the RET 
promoter so far. Indeed, a previous finding from Bachetti et al showed that Phox2b 
confers its full transactivation function with the proximal 360bp RET promoter 
(Bachetti et al., 2005), and it is believed that the putative binding motif(s) is residing 
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between +53 and -307.  In this study, we used a series of 5’ deletion mutants to further 
localize the Phox2b responsive region at -6/-178 of the RET promoter. Again, no 
putative Phox2b binding site (‘ATTA’ or ‘TAAT’) could be identified in this fragment, 
implying that Phox2b may not bind onto the RET promoter directly. This observation, 
on the other hand, reinforces the hypothesis that Phox2b may act as a bridge to recruit 
other transcriptional regulators to form a transcription complex, in turn, mediates the 
RET transcription. Sequence analysis showed that there are three potential binding sites 
for SP1 protein (SP1) and two for Kruppel-like factor (BKLF), and one for Hes1 within 
this 172bp. It suggests that Hes1, SP1 or KLF may interact with Phox2b to mediate RET 
transcription. Noteworthy, Hes1 and KLF4 are expressed in neural crest progenitor 
(unpublished data) and implicated in neural stem cell maintenance and neurogenesis 
(Cau et al., 2000;Li et al., 2005). Therefore, interaction between Phox2b and these two 
factors may contribute to the neural crest specific expression of RET and ENS 
development. Future study on the functional interaction between these factors may 
further delineate the underlying mechanism by which Phox2b mediates the neural crest 
specific expression of RET. 
Several models have been proposed to explain the co-operation mechanism 
among transcription factors. The ‘kinetics model’ suggests that different transcription 
factors may accelerate different steps, such as the assembly of transcription complex 
and elongation of the transcript  (Herschlag and Johnson, 1993). If more than one rate-
determining step is accelerated, the transcription efficiency will be increased 
exponentially. However, if only one rate-determining step was accelerated, the 
transcription efficiency would increase modestly. The co-operative DNA binding model 
suggests that the synergism could be achieved by the DNA binding of a transcription 
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factor which may increase the DNA binding affinity of another transcription factor.
 In our system, the additive effect between Nkx2-1 and Sox10 or Phox2b in RET 
transcription regulation is best explained under the kinetics model whereby Nkx2-1 may 
only contribute to the Sox10 or Phox2b-regulated transcriptional step. If these 
transcription factors were implicated in the same rate-determining step, the transcription 
efficiency would only be increased additively (Herschlag and Johnson, 1993). 
Alternatively, Phox2b and Sox10 may not have direct interaction with Nkx2-1.  They 
may contribute to the Nkx2-1 regulated RET transcription through other coactivators or 
tissue specific transcriptional factors.  
Evidently, Nkx2 and Pax family members have been shown to have functional 
cross-talk in various systems. For instance, NKX2-1 directly interacts with PAX8 to 
regulate thyroid-specific expression of thyroglobulin (Tg) (Espinoza et al., 2001). In the 
developing pancreata, Nkx2-2 and Pax4, despite of working through two independent 
pathways, they both are involved in mediating the expression of same set of pancreatic 
beta-cell early differentiation markers such as Hlxb9, Pdx1 as well as insulin (Sosa-
Pineda, 2004). Therefore, Nkx and Pax can work co-ordinately either by direct 
interaction or via parallel pathways. Here, we have shown that Nkx2-1 does not have 
direct interaction with Pax3. However, we cannot rule out the possibility that they 
would work in parallel to provide signal refinement for the RET expression during ENS 
development.   
In sum, this is the first integrated study showing the potential functional 
interaction of multiple transcription factors with Nkx2-1 to mediate the RET 
transcription. A delicate balance between these factors will therefore ensure the proper 
expression of RET during different developmental windows. Identification of promoter 
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region responsible for Phox2b transactivation further confirms its biological 
significance on RET expression. It also supports the notion that both functional and 
genetic interactions between PHOX2B and RET contribute to the development of HSCR 
disease (Miao et al., 2007). 
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FIGURE LEGENDS 
 
Figure 1. Expression of RET, NKX2-1, Phox2b, Sox10 and Pax3 in SK-N-SH and 
Neuro-2A cells. RT-PCR analysis indicates that RET, NKX2-1, Phox2b, Sox10 and 
Pax3 are differentially expressed in two neuroblastoma cell lines (SK-N-SH and Neuro-
2A). +ve: positive control; -ve: negative control. 
 
Figure 2. Expression of PHOX2B and RET in myenteric plexus of human gut. 
Human postnatal gut section was stained with anti-RET and anti-PHOX2B antibodies. 
RET (red) and PHOX2B (green) are colocalized in neuroblast of the myenteric plexus. 
lm, longitudinal muscle; cm, circular muscle; mp, myenteric plexus. Scale bars, 50 µm. 
 
Figure 3. Transactivation activities of Nkx2-1, Sox10 or Pax3 on RET promoter. (A) 
DNA sequence of the RET promoter used in this study. The binding sites of Sox10, 
Pax3 and Nkx2-1 were highlighted. Luciferase assays shows that (B) Nkx2-1, (C) 
Sox10 and (D) Pax3 activate RET promoter significantly. Luciferase activity was 
normalized with Renilla luciferase to obtain relative luciferase unit (RLU). Data are 
shown as the fold increase in relative promoter activities compared with that in the 
control (empty vector). Bars bearing “*” are statistically different from the control 
(p<0.05). 
 
Figure 4. Identification of Phox2b responsive promoter region in RET gene. (A) 
Luciferase assay shows that Phox2b significantly activates RET transcription. (B) 
Deletion mutation analysis was performed with three sequential 5’ deletion mutants of 
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the RET promoter. RET-372bp, RET-200bp and RET-100bp reporter constructs contain 
the proximal 372bp, 200bp and 100bp of RET promoter. Deletion of -6/-178 of RET 
promoter results in loss of Phox2b-mediated RET transcription. Luciferase activity was 
normalized with Renilla luciferase to obtain relative luciferase unit (RLU). Data are 
shown as the percentage change in relative promoter activities compared with that in the 
control (empty vector). Bars bearing “*” are statistically different from the control 
(p<0.05). (C) In silico prediction of putative transcription factor binding sites residing 
on the region -6/-178 of RET promoter. The putative binding motifs are underlined and 
labeled accordingly. 
 
Figure 5. Functional interaction of Nkx2-1 with Phox2b, Sox10 and Pax3 on RET 
transcription. Luciferase assays were performed in Neuro2A cells to examine the 
potential interaction between Nkx2-1 with (A) Phox2b, (B) Sox10 and (C) Pax3. 
Luciferase activity was normalized with Renilla luciferase to obtain relative luciferase 
unit (RLU). Data are shown as the fold increase in relative promoter activities compared 
with that in the control (empty vector). Bars bearing “*” are statistically different from 
the control (p<0.05). 
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Figure 3 
A)  
     -3516 acctcaatag cccgatgggg gagcagaggg cagtggcaga cagatgggaa actgaggcac 
     -3456 cgaccacttt gctaacagtg cacacagcca gcctcagagt ctgtgcttcc aaccaccatg 
SOX10
     -3396 tcacactgcc catgggaggg acctggaccc ctgcccacgc ccactctgag aggcctcggt 
PAX3
     -3336 cagcagttcc aggaatgcca cccagccttc cagtatcacc aggaccgagc tgcgctcttg 
      … … … … … … … … … … … … … … … … … … … … … … 
       -96 accccacccg cctccggccc cgcctggccc acccctggac cgcccccgcc ccgccccgcc 
       -36 cctacccgct cctcggcgca gccggcgctt gcctagcttc agtcccgcga ccgaagcagg 
NKX2-1
+1
       +26 gcgcgcagca gcgctgagtg ccccggaacg tgcgtcgcgc ccccagtgtc cgtcgcgtcc 
+86 gccgcgcccc gggcggggat ggggcggcca gactgagcgc cgcacccgcc atccagaccc 
+146 gccggcccta gccgcagtcc ctccagccgt ggccccagcg cgcacgggcg atggcgaagg 
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Figure 4  
A) 
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C) 
-178 cccgcactga gctcctacac gcgccggccc cggccgcacc ccgcgcacgc agagcaagca  
-118 ctggagcccc gccccttccc gcaccccacc cgcctccggc cccgcctggc ccacccctgg 
HES1
SP1 BKLF BKLF 
0-58 accgcccccg ccccgccccg cccctacccg ctcctcggcg cagccggcgc tt 
SP1 SP1
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Figure 5  
A) 
0.00
0.5
4.5
5.0
0
0
0
0
0
*
P<0.001 P<0.001 P<0.001
0
1.0
1.5
2.0
2.5
3.0
3.5
4.0
0
0
0
0
Empty Vector Phox2b Nkx2-1 Phox2b /Nkx2-1
 
B)                                                                                                            
 
0.0000
0.5000
1.0000
1.5000
2.0000
2.5000
3.0000
3.5000
4.0000
4.5000
1 2 3 4  
C) 
 
0.0000
0.5000
1.0000
1.5000
2.0000
2.5000
1 2 3 4  
P<0.001P<0.001P<0.001 
P=0.152P=0.061P<0.001 
*
*
* *
*
*
Empty ector Phox2b Nkx2-1 Phox2b/ kx2-1 
5 
 
4 
 
3 
R
el
at
iv
e 
L
uc
ife
ra
se
 U
ni
t (
fo
ld
) 
 
2 
 
1 
 
0 
Empty Vector Sox10 Nkx2-1 Sox10/Nkx2-1 
 
4 
R
el
at
iv
e 
L
uc
ife
ra
se
 U
ni
t (
fo
ld
) 
 
 
1
2
 
0
3 
2 
 
 
 
 
Empty Vector Pax3 Nkx2-1 Pax3/Nkx2-1 
 
 
 
 
1 
 
 
 
*
*
R
el
at
iv
e 
L
uc
ife
ra
se
 U
ni
t (
fo
ld
) 
 25
